TrialAntimicrobial agents and chemotherapy2018

Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants.

Nicola Gargano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.